Metabolism and chromatin dynamics in health and disease

Molecular Aspects of Medicine

Volumn 54, Issue , 2017, Pages 1-15

  Rodriguez, Hanah ^a,b   Rafehi, Haloom ^a   Bhave, Mrinal ^b   El Osta, Assam ^a,c,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Chromatin; Diabetes; Epigenetics; Glucose; Histones; Metabolism

Indexed keywords

7 (3,5 DIMETHYL 4 ISOXAZOLYL) 1,3 DIHYDRO 8 METHOXY 1 [1 (2 PYRIDINYL)ETHYL] 2H IMIDAZO[4,5 C]QUINOLIN 2 ONE; GIVINOSTAT; HISTONE DEACETYLASE INHIBITOR; HISTONE LYSINE METHYLTRANSFERASE INHIBITOR; SET7; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT; GLUCOSE;

AMINO ACID METABOLISM; CELL METABOLISM; CHROMATIN STRUCTURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA DEMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE DEACETYLATION; HISTONE DEMETHYLATION; HISTONE METHYLATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; KIDNEY DISEASE; KIDNEY HYPERTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; REVIEW; ANIMAL; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASES; HEALTH; METABOLISM; PROTEIN PROCESSING;

ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE; GLUCOSE; HEALTH; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 85008675434     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.09.004     Document Type: Review

References (222)

1. Advani, A., Huang, Q., Thai, K., Advani, S.L., White, K.E., Kelly, D.J., et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am. J. Pathol 178:5 (2011), 2205–2214.
2. Aguilo, F., Li, S., Balasubramaniyan, N., Sancho, A., Benko, S., Zhang, F., et al. Deposition of 5-Methylcytosine on enhancer RNAs enables the coactivator function of PGC-1alpha. Cell Rep 14:3 (2016), 479–492.
3. Anderson, D., Cordell, H.J., Fakiola, M., Francis, R.W., Syn, G., Scaman, E.S.H., et al. First genome-wide association study in an Australian aboriginal population provides insights into genetic risk factors for body mass index and type 2 diabetes. PLoS ONE, 10(3), 2015 e0119333.
4. Anderson, O.S., Sant, K.E., Dolinoy, D.C., Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem 23:8 (2012), 853–859.
5. Antos, C.L., McKinsey, T.A., Dreitz, M., Hollingsworth, L.M., Zhang, C.-L., Schreiber, K., et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem 278:31 (2003), 28930–28937.
6. Babu, D.A., Deering, T.G., Mirmira, R.G., A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis. Mol. Genet. Metab 92 (2007), 43–55.
7. Bai, P., Nagy, L., Fodor, T., Liaudet, L., Pacher, P., Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol. Metab 26:2 (2015), 75–83.
8. Barrès, R., Osler, M.E., Yan, J., Rune, A., Fritz, T., Caidahl, K., et al. Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density. Cell Metab 10:3 (2009), 189–198.
9. Barrès, R., Yan, J., Egan, B., Treebak, J.T., Rasmussen, M., Fritz, T., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 15:3 (2012), 405–411.
10. Bendale, D.S., Karpe, P.A., Chhabra, R., Shete, S.P., Shah, H., Tikoo, K., 17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation. Br. J. Pharmacol 170:4 (2013), 779–795.
11. Bernstein, B.E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D.K., Huebert, D.J., et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120:2 (2005), 169–181.
12. Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., et al. The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol 28:10 (2010), 1045–1048.
13. Bleich, S., Semmler, A., Frielling, H., Thumfart, L., Muschler, M., Hillemacher, T., et al. Genetic variants of methionine metabolism and DNA methylation. Epigenomics 6:6 (2014), 585–591.
14. Bond, M.R., Hanover, J.A., A little sugar goes a long way: the cell biology of O-GlcNAc. J. Cell Biol 208:7 (2015), 869–880.
15. Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E.K., et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58 (2009), 1229–1236.
16. Brasier, A.R., Recinos, A., Eledrisi, M.S., Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol 22:8 (2002), 1257–1266.
17. Brøns, C., Jacobsen, S., Nilsson, E., Rönn, T., Jensen, C.B., Storgaard, H., et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J. Clin. Endocrinol. Metab 95:6 (2010), 3048–3056.
18. Buescher, J.L., Musselman, L.P., Wilson, C.A., Lang, T., Keleher, M., Baranski, T.J., et al. Evidence for transgenerational metabolic programming in Drosophila. Dis. Model. Mech 6:5 (2013), 1123–1132.
19. Bungard, D., Fuerth, B.J., Zeng, P.Y., Faubert, B., Maas, N.L., Viollet, B., et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329:5996 (2010), 1201–1205.
20. Buraczynska, M., Dragan, M., Buraczynska, K., Orlowska-Kowalik, G., Ksiazek, A., Matrix metalloproteinase-2 (MMP-2) gene polymorphism and cardiovascular comorbidity in type 2 diabetes patients. J. Diabetes Complications 29:6 (2015), 829–833.
21. Buse, M.G., Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab 290:1 (2006), E1–E8.
22. Cai, L., Sutter, B.M., Li, B., Tu, B.P., Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42:4 (2011), 426–437.
23. Canto, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:7241 (2009), 1056–1060.
24. Chalmers, J., Cooper, M.E., UKPDS and the legacy effect. N. Engl. J. Med 359:15 (2008), 1618–1620.
25. Chen, J., Fontes, G., Saxena, G., Poitout, V., Shalev, A., Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid–induced ER stress–mediated β-cell death. Diabetes 59:2 (2010), 440–447.
26. Chen, J., Guo, Y., Zeng, W., Huang, L., Pang, Q., Nie, L., et al. ER stress triggers MCP-1 expression through SET7/9-induced histone methylation in the kidneys of db/db mice. Am. J. Physiol. Renal Physiol 306:8 (2014), F916–F925.
27. Chen, Z., Miao, F., Paterson, A.D., Lachin, J.M., Zhang, L., Schones, D.E., et al. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort. Proc. Natl. Acad. Sci. U.S.A. 113:21 (2016), E3002–E3011.
28. Choi, D., Oh, K.-J., Han, H.-S., Yoon, Y.-S., Jung, C.-Y., Kim, S.-T., et al. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology 56:4 (2012), 1546–1556.
29. Chou, D.H., Holson, E.B., Wagner, F.F., Tang, A.J., Maglathlin, R.L., Lewis, T.A., et al. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis. Chem. Biol 19:6 (2012), 669–673.
30. Christensen, D.P., Gysemans, C., Lundh, M., Dahllöf, M.S., Noesgaard, D., Schmidt, S.F., et al. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection. Proc. Natl. Acad. Sci. U.S.A. 111:3 (2014), 1055–1059.
31. Chu, C.-S., Lo, P.-W., Yeh, Y.-H., Hsu, P.-H., Peng, S.-H., Teng, Y.-C., et al. O-GlcNAcylation regulates EZH2 protein stability and function. Proc. Natl. Acad. Sci. U.S.A. 111:4 (2014), 1355–1360.
32. Ciccarelli, M., Vastolo, V., Albano, L., Lecce, M., Cabaro, S., Liotti, A., et al. Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle. Diabetologia 59:1 (2016), 176–186.
33. Dalgaard, K., Landgraf, K., Heyne, S., Lempradl, A., Longinotto, J., Gossens, K., et al. Trim28 haploinsufficiency triggers bi-stable epigenetic obesity. Cell 164:3 (2016), 353–364.
34. Das, M., Sha, J., Hidalgo, B., Aslibekyan, S., Do, A.N., Zhi, D., et al. Association of DNA methylation at CPT1A locus with metabolic syndrome in the genetics of lipid lowering drugs and diet network (GOLDN) study. PLoS ONE, 11(1), 2016 e0145789.
35. DCCT, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med 329:14 (1993), 977–986.
36. DCCT/EDIC, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med 342:6 (2000), 381–389.
37. DCCT/EDIC, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:16 (2003), 2159–2167.
38. De Oliveira, R.M., Sarkander, J., Kazantsev, A.G., Outeiro, T.F., SIRT2 as a therapeutic target for age-related disorders. Front. Pharmacol, 3, 2012, 82.
39. Deering, T.G., Ogihara, T., Trace, A.P., Maier, B., Mirmira, R.G., Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 58:1 (2009), 185–193.
40. Dhawan, S., Tschen, S.-I., Zeng, C., Guo, T., Hebrok, M., Matveyenko, A., et al. DNA methylation directs functional maturation of pancreatic β cells. J. Clin. Invest 125:7 (2015), 2851–2860.
41. Dunn, G.A., Bale, T.L., Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology 150:11 (2009), 4999–5009.
42. Durning, S.P., Flanagan-Steet, H., Prasad, N., Wells, L., O-linked beta-N-acetylglucosamine (O-GlcNAc) acts as a glucose sensor to epigenetically regulate the insulin gene in pancreatic beta cells. J. Biol. Chem 291:5 (2016), 2107–2118.
43. El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P.L., Roeder, R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med 205:10 (2008), 2409–2417.
44. Eom, G.H., Nam, Y.S., Oh, J.G., Choe, N., Min, H.K., Yoo, E.K., et al. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Circ. Res 114:7 (2014), 1133–1143.
45. Evertts, A.G., Zee, B.M., Dimaggio, P.A., Gonzales-Cope, M., Coller, H.A., Garcia, B.A., Quantitative dynamics of the link between cellular metabolism and histone acetylation. J. Biol. Chem 288:17 (2013), 12142–12151.
46. Fang, S., Tsang, S., Jones, R., Ponugoti, B., Yoon, H., Wu, S.-Y., et al. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J. Biol. Chem 283:50 (2008), 35086–35095.
47. Feil, S., Fehrenbacher, B., Lukowski, R., Essmann, F., Schulze-Osthoff, K., Schaller, M., et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res 115:7 (2014), 662–667.
48. Feldman, J.L., Dittenhafer-Reed, K.E., Denu, J.M., Sirtuin catalysis and regulation. J. Biol. Chem 287:51 (2012), 42419–42427.
49. Filippakopoulos, P., Knapp, S., Targeting bromodomains: epigenetic readers of lysine acetylation. Nat. Rev. Drug Discov 13:5 (2014), 337–356.
50. Forsythe, M.E., Love, D.C., Lazarus, B.D., Kim, E.J., Prinz, W.A., Ashwell, G., et al. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. U.S.A. 103:32 (2006), 11952–11957.
51. Francis, J., Chakrabarti, S.K., Garmey, J.C., Mirmira, R.G., Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription. J. Biol. Chem 280 (2005), 36244–36253.
52. Fu, W., Farache, J., Clardy, S.M., Hattori, K., Mander, P., Lee, K., et al. Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and beta cells. elife, 3, 2014, e04631.
53. Fujiki, K., Kano, F., Shiota, K., Murata, M., Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 7:1 (2009), 1–14.
54. Fullston, T., Ohlsson Teague, E.M.C., Palmer, N.O., DeBlasio, M.J., Mitchell, M., Corbett, M., et al. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J. 27:10 (2013), 4226–4243.
55. Gæde, P., Vedel, P., Larsen, N., Jensen, G.V.H., Parving, H.-H., Pedersen, O., Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med 348:5 (2003), 383–393.
56. Gao, C., Chen, G., Liu, L., Li, X., He, J., Jiang, L., et al. Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells. J. Diabetes Res, 2013, 2013, 589474.
57. Gao, Z., Xu, C.W., Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells. Biochem. Biophys. Res. Commun 404:1 (2011), 428–433.
58. Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res 107:9 (2010), 1058–1070.
59. Gilbert, R.E., Huang, Q., Thai, K., Advani, S.L., Lee, K., Yuen, D.A., et al. Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Kidney Int 79:12 (2011), 1312–1321.
60. Gniuli, D., Calcagno, A., Caristo, M.E., Mancuso, A., Macchi, V., Mingrone, G., et al. Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny. J. Lipid Res 49:9 (2008), 1936–1945.
61. Gray, S.P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A.C., et al. NADPH oxidase 1 plays a key role in diabetes mellitus–accelerated atherosclerosis. Circulation 127:18 (2013), 1888–1902.
62. Han, H.-S., Jung, C.-Y., Yoon, Y.-S., Choi, S., Choi, D., Kang, G., et al. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism. Sci. Signal, 7(314), 2014, ra19.
63. Hanzu, F.A., Musri, M.M., Sánchez-Herrero, A., Claret, M., Esteban, Y., Kaliman, P., et al. Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes. Obesity (Silver Spring) 21:12 (2013), E616–E625.
64. 174 is required for endothelial CXCL11 gene induction in response to TNF-α and IFN-γ costimulation. PLoS ONE, 11(2), 2016 e0148905.
65. Hart, G.W., Nutrient regulation of signaling and transcription by O-GlcNAcylation. FASEB J. 29:1 (2015), Supp–489.3.
66. Hattori, Y., Hattori, S., Sato, N., Kasai, K., High-glucose-induced nuclear factor kB activation in vascular smooth muscle cells. Cardiovasc. Res 46 (2000), 188–197.
67. Hayashida, S., Arimoto, A., Kuramoto, Y., Kozako, T., Honda, S., Shimeno, H., et al. Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem 339:1–2 (2010), 285–292.
68. He, Y.-F., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., et al. Tet-mediated formation of 5-Carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:6047 (2011), 1303–1307.
69. Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet 39:3 (2007), 311–318.
70. Hillman, S.L., Finer, S., Smart, M.C., Mathews, C., Lowe, R., Rakyan, V.K., et al. Novel DNA methylation profiles associated with key gene regulation and transcription pathways in blood and placenta of growth-restricted neonates. Epigenetics 10:1 (2015), 50–61.
71. Hirschey, M.D., Shimazu, T., Huang, J.Y., Schwer, B., Verdin, E., SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol 76 (2011), 267–277.
72. Hirschey, M.D., Shimazu, T., Jing, E., Grueter, C., Collins, A.M., Aouizerat, B., et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44:2 (2011), 177–190.
73. Holam, R.R., Paul, S.K., Bethel, A., Matthews, D.R., Neil, A.W., 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med 359 (2008), 1577–1589.
74. Holland, M., Lowe, R., Caton, P., Gemma, C., Carbajosa, G., Danson, A., et al. Early-life nutrition modulates the epigenetic state of specific rDNA genetic variants in mice. Science 353:6298 (2016), 495–498.
75. Hottiger, M.O., ADP-ribosylation of histones by ARTD1: an additional module of the histone code?. FEBS Lett 585:11 (2011), 1595–1599.
76. Houde, A.-A., Légaré, C., Biron, S., Lescelleur, O., Biertho, L., Marceau, S., et al. Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women. BMC Med. Genet 16:1 (2015), 1–10.
77. Huang, B., Yang, X.D., Zhou, M.M., Ozato, K., Chen, L.F., Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol 29:5 (2009), 1375–1387.
78. Ihnat, M.A., Thorpe, J.E., Kamat, C.D., Szabo, C., Green, D.E., Warnke, L.A., et al. Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling. Diabetologia 50:7 (2007), 1523–1531.
79. Ijaz, A., Tejada, T., Catanuto, P., Xia, X., Elliot, S.J., Lenz, O., et al. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int 75:4 (2009), 381–388.
80. Inagaki, T., Tachibana, M., Magoori, K., Kudo, H., Tanaka, T., Okamura, M., et al. Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14:8 (2009), 991–1001.
81. Inagaki, T., Iwasaki, S., Matsumura, Y., Kawamura, T., Tanaka, T., Abe, Y., et al. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis. J. Biol. Chem 290:7 (2015), 4163–4177.
82. Ishikawa-Kobayashi, E., Ushijima, K., Ando, H., Maekawa, T., Takuma, M., Furukawa, Y., et al. Reduced histone H3K9 acetylation of clock genes and abnormal glucose metabolism in ob/ob mice. Chronobiol. Int 29:8 (2012), 982–993.
83. Jankevicius, G., Hassler, M., Golia, B., Rybin, V., Zacharias, M., Timinszky, G., et al. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat. Struct. Mol. Biol 20:4 (2013), 508–514.
84. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293:5532 (2001), 1074–1080.
85. Jha, J.C., Gray, S.P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J. Am. Soc. Nephrol 25:6 (2014), 1237–1254.
86. Johnsson, A., Durand-Dubief, M., Xue-Franzén, Y., Rönnerblad, M., Ekwall, K., Wright, A., HAT–HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress. EMBO Rep 10:9 (2009), 1009–1014.
87. Kaelin, W.G. Jr., McKnight, S.L., Influence of metabolism on epigenetics and disease. Cell 153:1 (2013), 56–69.
88. Kanamaluru, D., Xiao, Z., Fang, S., Choi, S.-E., Kim, D.-H., Veenstra, T.D., et al. Arginine methylation by PRMT5 at a naturally occurring mutation site is critical for liver metabolic regulation by small heterodimer partner. Mol. Cell. Biol 31:7 (2011), 1540–1550.
89. Kanfi, Y., Peshti, V., Gil, R., Naiman, S., Nahum, L., Levin, E., et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 9:2 (2010), 162–173.
90. Kang, S., Tsai, L.T., Zhou, Y., Evertts, A., Xu, S., Griffin, M.J., et al. Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis. Nat. Cell Biol 17:1 (2015), 44–56.
91. Katari, S., Turan, N., Bibikova, M., Erinle, O., Chalian, R., Foster, M., et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum. Mol. Genet 18:20 (2009), 3769–3778.
92. Kaur, H., Chen, S., Xin, X., Chiu, J., Khan, Z.A., Chakrabarti, S., Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes 55:11 (2006), 3104–3111.
93. Keating, S., El-Osta, A., Transcriptional regulation by the Set7 lysine methyltransferase. Epigenetics 8:4 (2013), 361–372.
94. Keating, S.T., El-Osta, A., Epigenetic changes in diabetes. Clin. Genet 84 (2013), 1–10.
95. Keating, S.T., El-Osta, A., Epigenetics and metabolism. Circ. Res 116:4 (2015), 715–736.
96. Keating, S.T., Ziemann, M., Okabe, J., Khan, A.W., Balcerczyk, A., El-Osta, A., Deep sequencing reveals novel Set7 networks. Cell. Mol. Life Sci 71:22 (2014), 4471–4486.
97. Kemper, J.K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab 10:5 (2009), 392–404.
98. Khurana, I., Kaspi, A., Ziemann, M., Block, T., Connor, T., Spolding, B., et al. DNA methylation regulates hypothalamic gene expression linking parental diet during pregnancy to the offspring's rick of obesity in Psammomys obesus. Int. J. Obes 40:7 (2016), 1079–1088.
99. Kilberg, M.S., Terada, N., Shan, J., Influence of amino acid metabolism on embryonic stem cell function and differentiation. Adv. Nutr 7:4 (2016), 780S–789S.
100. Kim, D.-I., Park, M.-J., Choi, J.-H., Kim, I.-S., Han, H.-J., Yoon, K.-C., et al. PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independent manners. Oxid. Med. Cell. Longev, 2015, 2015, 617919.
101. Knutson, S.K., Chyla, B.J., Amann, J.M., Bhaskara, S., Huppert, S.S., Hiebert, S.W., Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27:7 (2008), 1017–1028.
102. Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B.A., Olson, E.N., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:22 (2006), 2579–2588.
103. Kouzarides, T., Chromatin modifications and their function. Cell 128 (2007), 693–705.
104. Kumar, S., Tikoo, K., Role of H3K36me2 in palmitate induced metabolic memory in human podocytes. FASEB J., 29, 2015, 877.6.
105. Kuroda, A., Rauch, T.A., Todorov, I., Ku, H.T., Al-Abdullah, I.H., Kandeel, F., et al. Insulin gene expression is regulated by DNA methylation. PLoS ONE, 4(9), 2009 e6953.
106. Kuzmochka, C., Abdou, H.-S., Haché, R.J.G., Atlas, E., Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT/enhancer-binding protein α (C/EBPα) expression and preadipocyte differentiation. Endocrinology 155:12 (2014), 4762–4773.
107. Lee, H.B., Noh, H., Seo, J.Y., Yu, M.R., Ha, H., Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy. Kidney Int 72 (2007), S61–S66.
108. Lee, J., Saha, P.K., Yang, Q.-H., Lee, S., Park, J.Y., Suh, Y., et al. Targeted inactivation of MLL3 histone H3–Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc. Natl. Acad. Sci. U.S.A. 105:49 (2008), 19229–19234.
109. Lee, J., Carrer, A., Shah, S., Snyder, N.W., Wei, S., Venneti, S., et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab 20:2 (2014), 306–319.
110. Lee, S., Lee, J., Lee, S.-K., Lee, J.W., Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol. Endocrinol 22:6 (2008), 1312–1319.
111. Lenoir, O., Flosseau, K., Xia Ma, F., Blondeau, B., Mai, A., Bassel-Duby, R., et al. Specific Control of Pancreatic Endocrine β and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9. Diabetes 60 (2011), 2861–2871.
112. Lerin, C., Rodgers, J.T., Kalume, D.E., Kim, S.H., Pandey, A., Puigserver, P., GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 3:6 (2006), 429–438.
113. Leung, A., Trac, C., Jin, W., Lanting, L., Akbany, A., Saetrom, P., et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ. Res 113:3 (2013), 266–278.
114. Lewis, E.C., Blaabjerg, L., Størling, J., Ronn, S.G., Mascagni, P., Dinarello, C.A., et al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro. Mol. Med 17:5–6 (2011), 369–377.
115. Li, N., Chen, J., ADP-ribosylation: activation, recognition, and removal. Mol. Cells 37:1 (2014), 9–16.
116. Li, S., Swanson, S.K., Gogol, M., Florens, L., Washburn, M.P., Workman, J.L., et al. Serine and SAM responsive complex SESAME regulates histone modification crosstalk by sensing cellular metabolism. Mol. Cell 60:3 (2015), 408–421.
117. Li, X., SIRT1 and energy metabolism. Acta Biochim. Biophys. Sin. (Shanghai) 45:1 (2013), 51–60.
118. Li, Y., Reddy, M.A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-κB-dependent inflammatory genes: relevance to diabetes and inflammation. J. Biol. Chem 283 (2008), 26771–26781.
119. Ling, C., Poulsen, P., Simonsson, S., Rönn, T., Holmkvist, J., Almgren, P., et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest 117:11 (2007), 3427–3435.
120. Liu, X., Chen, Z., Xu, C., Leng, X., Cao, H., Ouyang, G., et al. Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation. Nucleic Acids Res 43:10 (2015), 5081–5098.
121. Liu, X.-S., Little, J.B., Yuan, Z.-M., Glycolytic metabolism influences global chromatin structure. Oncotarget 6:6 (2015), 4214–4225.
122. Locke, M., Anderson, J., NF-κB activation in organs from STZ-treated rats. Appl. Physiol. Nutr. Metab 36 (2011), 121–127.
123. Loenarz, C., Schofield, C.J., Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci 36:1 (2011), 7–18.
124. Louet, J.-F., Chopra, A.R., Sagen, J.V., An, J., York, B., Tannour-Louet, M., et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab 12:6 (2010), 606–618.
125. Lu, T.C., Wang, Z.-H., Feng, X., Chuang, P.Y., Fang, W., Shen, Y., et al. Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. Kidney Int 76:1 (2009), 63–71.
126. Maganti, A.V., Maier, B., Tersey, S.A., Sampley, M.L., Mosley, A.L., Özcan, S., et al. Transcriptional activity of the islet β cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. J. Biol. Chem 290:15 (2015), 9812–9822.
127. Makino, A., Dai, A., Han, Y., Youssef, K.D., Wang, W., Donthamsetty, R., et al. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice. Am. J. Physiol. Cell Physiol 309:9 (2015), C593–C599.
128. Malmgren, S., Spegel, P., Danielsson, A.P., Nagorny, C.L., Andersson, L.E., Nitert, M.D., et al. Coordinate changes in histone modifications, mRNA levels, and metabolite profiles in clonal INS-1 832/13 beta-cells accompany functional adaptations to lipotoxicity. J. Biol. Chem 288:17 (2013), 11973–11987.
129. Martin, C., Zhang, Y., The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol 6:11 (2005), 838–849.
130. McGee, S.L., van Denderen, B.J., Howlett, K.F., Mollica, J., Schertzer, J.D., Kemp, B.E., et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57:4 (2008), 860–867.
131. Mentch, S.J., Mehrmohamadi, M., Huang, L., Liu, X., Gupta, D., Mattocks, D., et al. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab 22:5 (2015), 861–873.
132. Messner, S., Altmeyer, M., Zhao, H., Pozivil, A., Roschitzki, B., Gehrig, P., et al. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res 38:19 (2010), 6350–6362.
133. Miao, F., Gonzalo, I.G., Lanting, L., Natarajan, R., In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem 279:17 (2004), 18091–18097.
134. Miao, F., Smith, D.D., Zhang, L., Min, A., Feng, W., Natarajan, R., Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57:12 (2008), 3189–3198.
135. Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 63 (2014), 1748–1762.
136. Mihaylova, M.M., Vasquez, D.S., Ravnskjaer, K., Denechaud, P.-D., Yu, R.T., Alvarez, J.G., et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145:4 (2011), 607–621.
137. Monnier, L.M., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:14 (2006), 1681–1687.
138. Mosley, A.L., Ozcan, S., Glucose regulates insulin gene transcription by hyperacetylation of histone H4. J. Biol. Chem 278:22 (2003), 19660–19666.
139. Mosley, A.L., Ozcan, S., The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose. J. Biol. Chem 279:52 (2004), 54241–54247.
140. Mosley, A.L., Corbett, J.A., Ozcan, S., Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. Mol. Endocrinol 18:9 (2004), 2279–2290.
141. Muniandy, S.Q., Qvist, R., Yan, G.O., Bee, C.J., Chu, Y.K., Rayappan, A.V., The oxidative stress of hyperglycemia and the inflammatory process in endothelial cells. J. Med. Invest 56 (2009), 6–10.
142. Musri, M.M., Carmona, M.C., Hanzu, F.A., Kaliman, P., Gomis, R., Párrizas, M., Histone demethylase LSD1 regulates adipogenesis. J. Biol. Chem 285:39 (2010), 30034–30041.
143. Nagaoka, K., Hino, S., Sakamoto, A., Anan, K., Takase, R., Umehara, T., et al. Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells. Mol. Cell. Biol 35:7 (2015), 1068–1080.
144. Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134:2 (2008), 329–340.
145. Ng, S.F., Lin, R.C.Y., Laybutt, D.R., Barres, R., Owens, J.A., Morris, M.J., Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring. Nature 467:7318 (2010), 963–966.
146. Nicodeme, E., Jeffrey, K.L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.W., et al. Suppression of inflammation by a synthetic histone mimic. Nature 468:7327 (2010), 1119–1123.
147. Nilsson, E., Jansson, P.A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M.K., et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63:9 (2014), 2962–2976.
148. Nitert, M.D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., et al. Impact of an Exercise Intervention on DNA Methylation in Skeletal Muscle From First-Degree Relatives of Patients With Type 2 Diabetes. Diabetes, 61(12), 2012, 3322.
149. Noh, H., Oh, E.Y., Seo, J.Y., Yu, M.R., Kim, Y.O., Ha, H., et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am. J. Physiol. Renal Physiol 297:3 (2009), F729–F739.
150. Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M.C., Cooper, M.E., et al. Distinguishing hyperglycemic changes by set7 in vascular endothelial cells. Circ. Res 110:8 (2012), 1067–1076.
151. Okabe, J., Fernandez, A.Z., Ziemann, M., Keating, S.T., Balcerczyk, A., El-Osta, A., Endothelial transcriptome in response to pharmacological methyltransferase inhibition. Chem. Med. Chem 9:8 (2014), 1755–1762.
152. Okamura, M., Inagaki, T., Tanaka, T., Sakai, J., Role of histone methylation and demethylation in adipogenesis and obesity. Organogenesis 6:1 (2010), 24–32.
153. Ooi, J.Y., Tuano, N.K., Rafehi, H., Gao, X.M., Ziemann, M., Du, X.J., et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Epigenetics 10:5 (2015), 418–430.
154. Öst, A., Lempradl, A., Casas, E., Weigert, M., Tiko, T., Deniz, M., et al. Paternal diet defines offspring chromatin state and intergenerational obesity. Cell 159:6 (2014), 1352–1364.
155. Paneni, F., Mocharla, P., Akhmedov, A., Costantino, S., Osto, E., Volpe, M., et al. Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ. Res 111:3 (2012), 278–289.
156. Paneni, F., Costantino, S., Battista, R., Castello, L., Capretti, G., Chiandotto, S., et al. Adverse epigenetic signatures by histone methyltransferase set7 contribute to vascular dysfunction in patients with type 2 diabetes. Circ. Cardiovasc. Gene 8 (2015), 150–158.
157. Pang, M., Kothapally, J., Mao, H., Tolbert, E., Ponnusamy, M., Chin, Y.E., et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am. J. Physiol. Renal Physiol 297:4 (2009), F996–F1005.
158. Park, J.H., Stoffers, D.A., Nicholls, R.D., Simmons, R.A., Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest 118:6 (2008), 2316–2324.
159. Peterson, C.W., Stoltzman, C.A., Sighinolfi, M.P., Han, K.S., Ayer, D.E., Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. Mol. Cell. Biol 30:12 (2010), 2887–2895.
160. Pfeiffer, L., Wahl, S., Pilling, L.C., Reischl, E., Sandling, J.K., Kunze, S., et al. DNA methylation of lipid-related genes affects blood lipid levels. Circ. Cardiovasc. Genet 8:2 (2015), 334–342.
161. Phang, J.M., Liu, W., Hancock, C., Bridging epigenetics and metabolism. Epigenetics 8:3 (2013), 231–236.
162. Pirola, L., Balcerczyk, A., Tothill, R.W., Haviv, I., Kaspi, A., Lunke, S., et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 21:10 (2011), 1601–1615.
163. Poitout, V., Robertson, R.P., Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr. Rev 29:3 (2008), 351–366.
164. Qi, W., Chen, X., Holian, J., Tan, C.Y.R., Kelly, D.J., Pollock, C.A., Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-γ mediate high glucose-induced thioredoxin-interacting protein. Am. J. Pathol 175:5 (2009), 1858–1867.
165. Rafehi, H., Balcerczyk, A., Lunke, S., Kaspi, A., Ziemann, M., Kn, H., et al. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res 24:8 (2014), 1271–1284.
166. Raichur, S., Teh, S.H., Ohwaki, K., Gaur, V., Long, Y.C., Hargreaves, M., et al. Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells. J. Mol. Endocrinol 49:3 (2012), 203–211.
167. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., Puigserver, P., Nutrient control of glucose homeostasis through a complex of PGC-α and SIRT1. Nature 434:7029 (2005), 113–118.
168. Rossetto, D., Avvakumov, N., Cote, J., Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7:10 (2012), 1098–1108.
169. Rönn, T., Poulsen, P., Hansson, O., Holmkvist, J., Almgren, P., Nilsson, P., et al. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 51:7 (2008), 1159–1168.
170. Rönn, T., Volkov, P., Davegårdh, C., Dayeh, T., Hall, E., Olsson, A.H., et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet, 9(6), 2013 e1003572.
171. Sakabe, K., Wang, Z., Hart, G.W., β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl. Acad. Sci. U.S.A. 107:46 (2010), 19915–19920.
172. Sasaki, K., Doi, S., Nakashima, A., Irifuku, T., Yamada, K., Kokoroishi, K., et al. Inhibition of SET domain–containing lysine methyltransferase 7/9 ameliorates renal fibrosis. J. Am. Soc. Nephrol 27:1 (2016), 203–2015.
173. Sharma, K., Ziyadeh, F.N., Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-b as a key mediator. Diabetes 44 (1995), 1139–1146.
174. Sheen-Chen, S.-M., Lin, C.-R., Chen, K.-H., Yang, C.-H., Lee, C.-T., Huang, H.-W., et al. Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. J. Gastroenterol 49:8 (2014), 1285–1297.
175. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J.R., Cole, P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:7 (2004), 941–953.
176. Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:6116 (2013), 211–214.
177. Shyh-Chang, N., Locasale, J.W., Lyssiotis, C.A., Zheng, Y., Teo, R.Y., Ratanasirintrawoot, S., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339:6116 (2013), 222–226.
178. Simone, C., Stiegler, P., Forcales, S.-V., Bagella, L., De Luca, A., Sartorelli, V., et al. Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300. Oncogene 23:12 (2004), 2177–2187.
179. Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:6647 (1997), 194–198.
180. Strakovsky, R.S., Zhang, X., Zhou, D., Pan, Y.-X., Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J. Physiol 589:11 (2011), 2707–2717.
181. Stratton, I.M., Adler, A.I., Neil, A.W., Matthews, D.R., Manley, S.E., Cull, C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000), 405–412.
182. Sun, C., Wang, M., Liu, X., Luo, L., Li, K., Zhang, S., et al. PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC-1α. Cell Rep 9:6 (2014), 2250–2262.
183. Sun, G., Reddy, M.A., Yuan, H., Lanting, L., Kato, M., Natarajan, R., Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol 21 (2010), 2069–2080.
184. Suter, M.A., Chen, A., Burdine, M.S., Choudhury, M., Harris, R.A., Lane, R.H., et al. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 26:12 (2012), 5106–5114.
185. Suter, M.A., Ma, J., Vuguin, P.M., Hartil, K., Fiallo, A., Harris, R.A., et al. In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model. Am. J. Obstet. Gynecol, 210(5), 2014, 463 e461-463.e411.
186. Tang, B.L., SIRT7 and hepatic lipid metabolism. Front. Cell Dev. Biol, 3, 2015, 1.
187. Tang, J., Yan, H., Zhuang, S., Histone deacetylases as targets for treatment of multiple diseases. Clin. Sci 124:11 (2013), 651–662.
188. Tannour-Louet, M., York, B., Tang, K., Stashi, E., Bouguerra, H., Zhou, S., et al. Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis. Mol. Endocrinol 28:10 (2014), 1707–1718.
189. Tateishi, K., Okada, Y., Kallin, E.M., Zhang, Y., Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458:7239 (2009), 757–761.
190. Teixeira, L., Rabouille, C., Rørth, P., Ephrussi, A., Vanzo, N.F., Drosophila Perilipin/ADRP homologue Lsd2 regulates lipid metabolism. Mech. Dev 120:9 (2003), 1071–1081.
191. Thurner, S., Klimek, P., Szell, M., Duftschmid, G., Endel, G., Kautzky-Willer, A., et al. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc. Natl. Acad. Sci. U.S.A. 110:12 (2013), 4703–4707.
192. Tobi, E.W., Goeman, J.J., Monajemi, R., Gu, H., Putter, H., Zhang, Y., et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat. Commun, 5, 2014, 5592.
193. Tsai, W.-W., Niessen, S., Goebel, N., Yates, J.R., Guccione, E., Montminy, M., PRMT5 modulates the metabolic response to fasting signals. Proc. Natl. Acad. Sci. U.S.A. 110:22 (2013), 8870–8875.
194. Tu, B.P., Mohler, R.E., Liu, J.C., Dombek, K.M., Young, E.T., Synovec, R.E., et al. Cyclic changes in metabolic state during the life of a yeast cell. Proc. Natl. Acad. Sci. U.S.A. 104:43 (2007), 16886–16891.
195. Udali, S., Guarini, P., Ruzzenente, A., Ferrarini, A., Guglielmi, A., Lotto, V., et al. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin. Epigenetics 7:1 (2015), 1–13.
196. Van Beneden, K., Geers, C., Pauwels, M., Mannaerts, I., Wissing, K.M., Van den Branden, C., et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. Toxicol. Appl. Pharmacol 271:2 (2013), 276–284.
197. Van Otterdijk, S.D., Michels, K.B., Transgenerational epigenetic inheritance in mammals: how good is the evidence?. FASEB J. 30:7 (2016), 2457–2465.
198. Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L., Reinberg, D., SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450:7168 (2007), 440–444.
199. Vella, S., Gnani, D., Crudele, A., Ceccarelli, S., De Stefanis, C., Gaspari, S., et al. EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. Int. J. Mol. Sci, 14(12), 2013, 24154.
200. Villeneuve, L.M., Reddy, M.A., Lanting, L.L., Wang, M., Meng, L., Natarajan, R., Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. U.S.A. 105:26 (2008), 9047–9052.
201. Wang, H.-J., Hsieh, Y.-J., Cheng, W.-C., Lin, C.-P., Lin, Y.-S., Yang, S.-F., et al. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α–mediated glucose metabolism. Proc. Natl. Acad. Sci. U.S.A. 111:1 (2014), 279–284.
202. Wang, L., Xu, S., Lee, J.-E., Baldridge, A., Grullon, S., Peng, W., et al. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis. EMBO J. 32:1 (2013), 45–59.
203. Wang, S.C., Dowhan, D.H., Eriksson, N.A., Muscat, G.E., CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. Biochem. J. 444:2 (2012), 323–331.
204. Wang, Z., Zang, C., Cui, K., Schones, D.E., Barski, A., Peng, W., et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138:5 (2009), 1019–1031.
205. Waterborg, J., Dynamics of histone acetylation in vivo. A function for acetylation turnover?. Biochem. Cell Biol 80:3 (2002), 363–378.
206. Wei, Y., Yang, C.-R., Wei, Y.-P., Ge, Z.-J., Zhao, Z.-A., Zhang, B., et al. Enriched environment-induced maternal weight loss reprograms metabolic gene expression in mouse offspring. J. Biol. Chem 290:8 (2015), 4604–4619.
207. Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., Thompson, C.B., ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:5930 (2009), 1076–1080.
208. West, A.C., Johnstone, R.W., New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest 124:1 (2014), 30–39.
209. Winkler, R., Benz, V., Clemenz, M., Bloch, M., Foryst-Ludwig, A., Wardat, S., et al. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes 61:2 (2012), 513–523.
210. Xia, X., Lemieux, M.E., Li, W., Carroll, J.S., Brown, M., Liu, X.S., et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. U.S.A. 106:11 (2009), 4260–4265.
211. Xu, H., Wu, X., Qin, H., Tian, W., Chen, J., Sun, L., et al. Myocardin-related transcription factor A epigenetically regulates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol 26:7 (2015), 1648–1660.
212. Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:1 (2011), 17–30.
213. Yang, H., Yang, T., Baur, J.A., Perez, E., Matsui, T., Carmona, J.J., et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130:6 (2007), 1095–1107.
214. Yang, X., Zhang, F., Kudlow, J., Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110 (2002), 69–80.
215. Yin, R., Mao, S.-Q., Zhao, B., Chong, Z., Yang, Y., Zhao, C., et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc 135:28 (2013), 10396–10403.
216. Yokomori, N., Tawata, M., Onaya, T., DNA demethylation during the differentiation of 3T3-L1 cells affects the expression of the mouse GLUT4 gene. Diabetes, 48(4), 1999, 685.
217. Yuan, H., Reddy, M.A., Sun, G., Lanting, L., Wang, M., Kato, M., et al. Involvement of p300/CBP and epigenetic histone acetylation in TGF-beta1-mediated gene transcription in mesangial cells. Am. J. Physiol. Renal Physiol 304:5 (2013), F601–F613.
218. Yuan, H., Reddy, M., Deshpande, S., Jia, Y., Park, J.T., Lanting, L., et al. Epigenetic histone modifications involved in pro-fibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid. Redox Signal 24:7 (2016), 361–375.
219. Zhang, J., Henagan, T.M., Gao, Z., Ye, J., Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. Endocrinology 152:5 (2011), 1829–1838.
220. Zhang, Z.-C., Liu, Y., Li, S.-F., Guo, L., Zhao, Y., Qian, S.-W., et al. Suv39h1 mediates AP-2α-dependent inhibition of C/EBPα expression during adipogenesis. Mol. Cell. Biol 34:12 (2014), 2330–2338.
221. Zhao, E., Ding, J., Xia, Y., Liu, M., Ye, B., Choi, J.-H., et al. KDM4C and ATF4 cooperate in transcriptional control of amino acid metabolism. Cell Rep 14:3 (2016), 506–519.
222. Zhou, S., Chen, H.-Z., Wan, Y.-Z., Zhang, Q.-J., Wei, Y.-S., Huang, S., et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ. Res 109:6 (2011), 639–648.